Articles

Podcasts

Videos

Sustained virologic response following direct acting antiviral treatment substantially reduced the all-cause mortality rate in patients with HCV.

DAA Treatment Reduces Risk of Death for Hepatitis C Patients

More than half of the patients in the study were treated for inflammatory bowel disease with infliximab.

Adverse Drug Reactions Underreported Following Biologic Therapy for IBD

The expansion for sofosbuvir/velpatasvir is supported by phase 2 data showing an 83% sustained virologic response or cure rate among patients as young as 3 years old.

FDA Expands Epclusa Label for Young Children with Chronic Hepatitis C

Patients included in the study had a median of 3 prior CDI episodes and 4 risk factors for recurrent infections. 

Bezlotoxumab Reduces Odds of Recurrent C Difficile for Organ Transplant Recipients

The UNITI studies have shown ustekinumab is effective at inducing and maintaining clinical remission in Crohn’s disease patients. 

Ustekinumab Does Not Reduce Extraintestinal Manifestations in Crohn’s Disease Patients

Using both tests to screen for colorectal cancer was more effective than just using colonoscopies alone. 

Joseph C. Anderson, MD: Adding mt-sDNA Tests to Colonoscopies 

Direct-acting antivirals has increased the need to treat children HCV patients before they begin to engage in dangerous behaviors.

HCV Prevalence Could Be Higher in Pediatrics Than Previously Thought

Vedolizumab treatment was associated with lower IMC recurrence rate after ICI resumption.



Reducing Recurrence of Immune-Mediated Colitis for Cancer Patients

Seres expects to move forward with plans for SER-109 as a novel treatment for CDI.

Matthew Henn, PhD: A Promising New C Difficile Treatment

More patients treated with risankizumab 360 mg achieved clinical remission than the induction-only control group. 

AbbVie Announces Topline Data for Risankizumab for Crohn’s Disease 

C Difficile Infection

C. difficile condition center page, resources on the topics of medical news and expert insight into Clostridium difficile can be found. Content includes articles, interviews, videos, podcasts, and breaking news on C. diff research, treatment, and drug development.

Gastroesophageal Reflux Disease (GERD)

Hepatitis C

Hepatitis C page, resources on the topics of medical news and expert insight into HCV can be found. Content includes articles, interviews, videos, podcasts, and breaking news on hepatitis C virus research, treatment, and drug development.

Irritable Bowel Syndrome

Peptic Ulcer

Ulcerative Colitis

Ulcerative Colitis condition center page, resources on the topics of medical news and expert insight into colitis can be found. Content includes articles, interviews, videos, podcasts, and breaking news on UC research, treatment, and drug development.

Gastroenterology condition center page is a comprehensive resource for clinical news and insights on digestive and GI conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for 

, IBS and IBD, Crohn's disease, and more.